A Review of the Safety and Efficacy of Sugammadex in Anesthetic Practice

摘要: Sugammadex, the first in a novel class of medications termed selective relaxant binding agents, was developed to rapidly and completely encapsulate aminosteroid neuromuscular blocking thus removing them from junction. When used properly, sugammadex has potential decrease incidence residual block it's associated complications, as well as, avoid side effects with cholinesterase inhibitors. Sugammadex may also have role management patients difficult airways rocuronium- induced anaphylaxis. Currently available over 70 countries worldwide, fears hypersensitivity reactions delayed release United States. The article looks examine anesthesia detail its pharmacologic profile.